Monday, December 23, 2024
More
    HomeHealthAmazon launches fixed pricing to treat hair loss, erectile dysfunction

    Amazon launches fixed pricing to treat hair loss, erectile dysfunction

    -


    A worker delivers Amazon packages in San Francisco on Oct. 24, 2024.

    David Paul Morris | Bloomberg | Getty Images

    Amazon on Thursday announced Prime members can access new fixed pricing to treat conditions like erectile dysfunction and men’s hair loss, its latest effort to compete with other direct-to-consumer marketplaces like Hims & Hers Health and Ro.

    Shares of Hims & Hers fell as much as 17% Thursday, on pace for its worst day.

    Amazon said in a blog post that Prime members can see the cost of a telehealth visit and their desired treatment before they decide to proceed with care for five common issues. Patients can access treatment for anti-aging skin care starting at $10 a month; motion sickness for $2 per use; erectile dysfunction at $19 a month; eyelash growth at $43 a month and men’s hair loss for $16 a month by using Amazon’s savings benefit Prime Rx at checkout.

    Amazon acquired primary care provider One Medical for roughly $3.9 billion in July 2022, and Thursday’s announcement builds on its existing Pay-per-visit telehealth offering. Video visits through the service cost $49, and messaging visits cost $29 where available. Users can get treatment for more than 30 common conditions like a sinus infection or pink eye.

    Medications filled through Amazon Pharmacy are eligible for discounted pricing and will be delivered to patients’ doors in standard Amazon packaging. Prime members will pay for the consultation and medication, but there are no additional fees, the blog post said.

    Amazon has been trying to break into the lucrative health-care sector for years. The company launched its own online pharmacy in 2020 following its acquisition of PillPack in 2018. Amazon introduced, and later shuttered, a telehealth service called Amazon Care, as well as a line of health and wellness devices.

    The company has also discontinued a secretive effort to develop an at-home fertility tracker, as CNBC reported Wednesday.

    –CNBC’s Annie Palmer contributed to this report



    Source link

    Must Read

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Trending